2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$28.08+$0.25 (+0.88%)
Price as of Sep 11, 2026 7:34 PM EDT- $4.8BMarket Cap
- 17.87%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$28.08+$0.25 (+0.88%)
ACAD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.83 | ||
Change | +$0.09 (+0.32%) | ||
Open | $27.98 | ||
High | $28.24 | ||
Low | $27.74 | ||
Previous Close | $27.74 | ||
Volume | 1,172,681 | ||
30-Day Average Volume | 1,386,766 | ||
1-Week Change | -0.68% | ||
1-Month Change | -5.37% | ||
1-Year Change | 17.87% | ||
3-Year Change | 2.58% | ||
5-Year Change | 72.96% | ||
Fundamentals | |||
Shares Outstanding | 172.3M | ||
Total Assets | $1.7B | ||
Market Cap | $4.8B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $308.0M | ||
Net Income | $31.5M | ||
Free Cash Flow | $95.7M | ||
EBIT | $46.5M | ||
EBITDA | $49.2M | ||
Net Working Capital | $863.1M | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 90 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 4 | ||
P/E | 155 | ||
PEG | 0 | ||
Price/Free Cash Flow | 50 | ||
Price/Operating Cash Flow | 48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue